ARHGAP24

Across TCGA pan-cancer cohorts, ARHGAP24 mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated ARHGAP24 data layer compared with 24 for mass-spec protein and 4 for mutation status.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher ARHGAP24 mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated ARHGAP24 expression acts as an unfavorable survival marker, although some lineages such as CCRCC show a favorable association.

CCRCC, LUAD, and HNSC are the cancer types where ARHGAP24 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	OS	Quartile	III,IV	0.860	0.430	.007	26	view →
LUAD	DFS	Tertile	III,IV	0.338	0.995	.002	23	view →
HNSC	DFS	Quartile	III,IV	0.727	0.985	.018	7	view →
GBM	OS	Median	All	0.802	0.906	.022	2	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

ARHGAP24–CCRCC (OS)

Open the CCRCC breakdown →